WithdrawnNot Applicable

A Comparison of the Outcomes of Distal Fingertip Amputations Treated With Either Artificial (Xeroform) or Biological Dressings

Stopped: lack of enrollment

United States0Started 2018-12-24

Plain-language summary

This is a prospective study looking to evaluate whether the treatment outcomes for patients who sustain a distal fingertip amputation are improved or no different when using biological dressings versus artificial dressings.

Who can participate

Age range100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All individuals presenting at Bellevue Hospital for evaluation and treatment of a finger amputation distal to the germinal matrix that present along with the amputated distal fingertip unit. Exclusion Criteria: * replantation candidate, incomplete distal finger-tip amputation

What they're measuring

Time to complete healing up to 3 Months

Timeframe: 3 months

Percentage of graft viability (for biological dressing only)

Timeframe: 1 week

Percentage of graft viability (for biological dressing only)

Timeframe: 3 weeks

Percentage of graft viability (for biological dressing only)

Timeframe: 6 weeks

Percentage of graft viability (for biological dressing only)

Timeframe: 3 months

Trial details

NCT IDNCT03968835

SponsorNYU Langone Health

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-05

View on ClinicalTrials.gov More Finger Injuries trials